CAR T
Showing of 12 results
![CAR T cell therapy in UH Wesley Center laboratory](/-/media/images/for-clinicians/articles-and-news/2024/06/cancer-cart-machine-187a0250-600x400-bf06395-700x.jpg?mw=304&h=326&w=304&la=en&hash=41219AB2E07AD43992178ACCD60FB388)
Multiple Myeloma Patients at UH Seidman Cancer Center Have New Immunotherapy Option
BAFF CAR T has important advantage for these patients - Innovations in Cancer | July 2024
![CAR T illustration](/-/media/images/for-clinicians/articles-and-news/2022/10/cart-illustration-gettyimages-1255446359.jpg?mw=304&h=284&w=304&la=en&hash=9B8C09FA0483408329DFEB28A0DB214E)
UH Seidman Researchers Slash Time Needed to Produce CAR T-Cells
Quicker process will get needed therapy to cancer patients who don’t have time to wait - Innovations in Cancer | Fall 2022
![CAR T illustration](/-/media/images/for-clinicians/articles-and-news/2022/10/cart-illustration-gettyimages-1255446359.jpg?mw=304&h=284&w=304&la=en&hash=9B8C09FA0483408329DFEB28A0DB214E)
Novel Strategy to Improve CAR T-cell Efficacy in Non-Hodgkin Lymphoma Revealed in Preclinical Studies
University Hospitals Seidman Cancer Center researchers part of team finding blocking a single receptor may combat T cell dysfunction associated with poor response to therapy - Innovations in Cancer | Summer 2022
![](/-/media/images/for-clinicians/articles-and-news/2022/01/lab-istock-14261014-700x750.jpg?mw=304&h=326&w=304&la=en&hash=FC48DFBDC3BA27049107816D4B1F066D)
Team Led by UH Seidman Cancer Center Researcher Develops and Validates Three-in-One CAR T Therapy
Approach detailed in the journal Nature Communications shows therapeutic potential of BAFF CAR T for treating multiple B cell cancers, using mouse models with high effectiveness and minimum side effects - Innovations in Cancer | Winter 2022
![CAR T illustration](/-/media/images/for-clinicians/articles-and-news/2022/10/cart-illustration-gettyimages-1255446359.jpg?mw=304&h=284&w=304&la=en&hash=9B8C09FA0483408329DFEB28A0DB214E)
Anti-CD19 CAR T-Cells Produced Locally at UH Seidman Cancer Center Induce High Remission Rates in B-cell Malignancies, Study Finds
Clinical trials published in Nature Communications detail advantages of local approach - Innovations in Cancer | Fall 2021
![CAR T illustration](/-/media/images/for-clinicians/articles-and-news/2022/10/cart-illustration-gettyimages-1255446359.jpg?mw=304&h=284&w=304&la=en&hash=9B8C09FA0483408329DFEB28A0DB214E)
Multiple Myeloma Patients at UH Seidman Cancer Center First in Ohio to Receive New CAR T-Cell Therapy
Patients also have access to promising clinical trial of vactosertib and pomalidomide - Innovations in Cancer | Summer 2021
![Mesothelin - positive](/-/media/images/for-clinicians/articles-and-news/2021/02/mesothelin-positive-700x750.jpg?mw=304&h=326&w=304&la=en&hash=E1D571621E8216F9AD163925974C65C2)
New Immunotherapy Center at UH Seidman Cancer Center Sets the Stage for Solutions
Center offers dozens of clinical trials, including soon a rare all-human protein CAR T trial for patients with certain hematologic malignancies - Innovations in Cancer | Winter 2021
![CAR T cells](/-/media/images/for-clinicians/articles-and-news/2020/11/gettyimages-864309570-car-t-700x750.jpg?mw=304&h=326&w=304&la=en&hash=B6851E342280F47C82C7F907CEC6D794)
More Specific Approach to CAR T Cell Therapy Shows Promise for B Cell Cancers
Investigational New Drug (IND) authorization is under way - Innovations in Cancer | Fall 2020